Newsletter Signup | Join Community
Chemotherapy, biomarker testing and precision cancer medicines and immunotherapy are used to treat stage IIIB-IV NSCLC.
Surgery, radiation, and systemic therapies are all used to treat stage IIIA NSCLC.
Liquid biopsy improves access to precision cancer medicines and expands NSCLC treatment options.
Prophylactic Cranial Irradiation may improve survival in small cell lung cancer but appears less effective with NSCLC
Initial treatment with the Keytruda checkpoint inhibitor immunotherapy has become a standard of care for PD-1 + NSCLC.
Understand the role of Tarceva™ in the management of EGFR positive Non-Small Cell Lung Cancer
HER 2 + Lung Cancer Treatment?
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and work to overcome the…
High incidence of ROS 1 false negative tests reported by U Colorado researchers.